↓ Skip to main content

Dove Medical Press

Article Metrics

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers

Overview of attention for article published in Neuropsychiatric Disease and Treatment, February 2015
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
19 Mendeley
Title
Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
Published in
Neuropsychiatric Disease and Treatment, February 2015
DOI 10.2147/ndt.s75176
Pubmed ID
Authors

Norio Yasui-Furukori, Masamichi Ishioka, Norio Sugawara, Hanako Furukori, Shuhei Kudo, Kazuhiko Nakamura

Abstract

The strong association between psychiatric patients who receive antipsychotics and the incidence of venous thromboembolism (VTE) is known. Although previous reports suggest that hyperprolactinemia often increases markers of activated coagulation, few studies have examined the direct relationship between the prolactin level elevated by antipsychotics and activated markers of activated coagulation.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 19 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 19 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 26%
Other 3 16%
Student > Ph. D. Student 3 16%
Lecturer 1 5%
Student > Bachelor 1 5%
Other 3 16%
Unknown 3 16%
Readers by discipline Count As %
Medicine and Dentistry 4 21%
Biochemistry, Genetics and Molecular Biology 2 11%
Neuroscience 2 11%
Psychology 1 5%
Social Sciences 1 5%
Other 1 5%
Unknown 8 42%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 March 2015.
All research outputs
#17,604,428
of 19,862,972 outputs
Outputs from Neuropsychiatric Disease and Treatment
#2,235
of 2,798 outputs
Outputs of similar age
#191,274
of 228,839 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#7
of 7 outputs
Altmetric has tracked 19,862,972 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,798 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 228,839 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one.